In this paper, I propose the hypothesis that as an LGA outgrows its blood supply, small areas of hypoxia develop. The cells best able to respond to this hypoxic stress are clonally selected, and the tumor progresses to become a GBM. These cells have the ability to promote angiogenesis, a higher proliferation potential, and a decreased response to therapeutic measures. I hypothesize that this effect is mediated by HRMs such as HIF-1␣. A better understanding of this process and, eventually, the development of treatments that target HIF-1␣ or similar HRMs in human gliomas could result in a better prognosis for patients with this devastating disease.
Hypoxia and Tumorigenesis
Glioblastoma multiforme is one of the most highly vascularized human tumors, but this microcirculation is functionally very inefficient compared with that of normal brain tissue. 14, 50, 60, 64, 150 Intratumoral necrosis, the hallmark of GBM, is found in both small and large tumors, suggesting that necrosis may not simply be due to inadequate vascular supply but instead may be a result of intrinsic molecular or genetic changes within the tumor. 117 Direct and indirect measurements of tumor hypoxia in human GBMs have not cleared up this controversy. 51, 100, 113, 151 Evidence suggests that hypoxia plays a role in the malignant transformation of cells and subsequent tumor growth (Fig. 1) . In a number of different human cancers, tissue hypoxia predicts the likelihood of metastases, 144 tumor recurrence, 59 resistance to chemotherapy and radiation therapy, 41, 118, 130, 159 invasion, 31,48 and decreased patient survival. 58, 156 In fact, the degree of necrosis within a GBM correlates inversely with patient outcome and survival. 52, 76, 80 Hypoxic stress has been linked to several phenotypic changes that are fundamental to malignant progression.
Direct Measurement of Tumor Hypoxia
Intracellular hypoxia can be measured by biochemical markers of tissue hypoxia. The nitroimidazole derivatives EF5 87 and pimonidazole 7, 121 have been used to label hypoxic cells in animal and human tumors. At low O 2 concentrations, these markers undergo bioreduction by nitroreductases and bind to cellular macromolecules, which can be measured using immunohistochemical methods. 121, 155 As a demonstration of this technique, we grew U251 GBM cells subcutaneously in athymic mice and after 60 days injected the mice with pimonidazole hydrochloride (Hypoxyprobe-1; Natural Pharmacia International, Inc., Belmont, MA). This drug is bioreductive-it becomes charged and trapped within the cell under hypoxic conditions. 111, 158 The tumors were removed and fixed in formalin. The tissue was placed on glass slides, and cells with pimonidazole (hypoxic cells) were visualized using immunohistochemical methods with an antipimonidazole monoclonal antibody.
7, 112 On similar sections, the tumor vasculature was visualized using antibodies directed against a vascular marker (CD31 monoclonal antibody; Santa Cruz Biotechnology, Santa Cruz, CA). The U251 cells showed significant areas of necrosis with surrounding areas of hypoxia that correlate with pimonidazole staining (Fig. 3) .
Polarographic O 2 microelectrodes have also been used to determine intratumoral hypoxia in various tumors but have produced mixed results in the limited number of brain tumors studied. 9, 29, 55, 69, 71, 113, 155 These studies of polarographic O 2 microelectrodes lack spatial correlation with preoperative imaging or intracellular hypoxia measurement. The lack of direct correlation between measurements of polarographic O 2 microelectrodes, biochemical data, and imaging studies might account for the discrepancy of the prior work. With current stereotactic techniques and the ability to register anatomical location by using the preoperative imaging studies described later, this may be overcome in the future.
Imaging Measurement of Tumor Vascularity, Hypoxia, and Perfusion
Peritumoral edema is a condition of increased vascular permeability associated with GBM that can be measured using MR imaging. This imaging technology has also been used to map changes in blood volume fraction and vascular functionality associated with angiogenesis. 143 Dynamic contrast-enhanced MR imaging can provide measurements of tumor perfusion and vascularity by using kinetic modeling of tumor contrast uptake over time. 10, 38, 94, 101, 142, 149 It has the potential to predict intratumoral blood flow and vascular permeability preoperatively. After data collection, the relative cerebral blood-volume maps are derived on a voxel-by-voxel basis from the dynamic imaging sets. One disadvantage is that the significant amount of postprocessing necessary for data acquisition is time consuming and requires technical expertise. 10, 32, 104, 143 Magnetic resonance spectroscopy is an emerging technology that allows for in vivo chemical analysis of tissue during MR imaging. 96 With this technology, the distributions of various metabolite concentrations including Nacetyl aspartate, N-phosphocholine (choline), and lactate can be determined. Increased lactate, choline, or creatinine and decreased N-acetyl aspartate reflect the neuronal tissue loss and increased membrane synthesis that is known to occur in GBM. 6, 44, 162 At present, whether increased lactate peaks are due predominantly to hypoxia or to increased tumor metabolism is not known.
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Positron emission tomography provides the ability to measure the concentrations of positron-emitting radioisotopes within the tissues of living patients. Positron emission tomography of 2-nitroimidazole compounds, such as [ 18 F]fluoromisonidazole, has been used to identify hypoxic tumors (including gliomas) in humans.
9, [114] [115] [116] The most studied of these compounds is [ 18 F]fluoromisonidazole, 122, 148 although its slow clearance from normoxic tissues and the difficulty in obtaining it has led to a search for newer radiotracers. Another compound, copper diacetylbis[N4-methylthiosemicarbazone] was recently discovered to have higher uptake in hypoxic tissues than the nitroimidazoles do, and it can yield high-quality images as soon as 20 minutes after injection. 84, 85, 97 It is also flexible in that it can be labeled with any of several positron-emitting copper radioisotopes. In addition to these advantages, it already has been used in a few human clinical trials. 13, 33, 39 Molecules associated with tumor vascularity, such as VEGF, have been correlated with peritumoral edema and an increase in brain tumor malignancy. 45 No direct imaging techniques are available to measure the presence of VEGF or similar molecules. At present, it appears that correlating imaging characteristics with tumor histology and biology, although indirect, is the best method available for examining these relationships. Among molecules that are thought to regulate angiogenesis are those under the control of hypoxic regulation.
Hypoxia-Inducible Molecules
The transcription factor HIF-1 is the best-characterized HRM. It is composed of two subunits, HIF-1␤ and HIF-1␣, both of which are constitutively expressed and not significantly altered by hypoxia. Although HIF-1␤ protein is found in normoxic cells, almost no HIF-1␣ protein can be detected under these conditions 66 because of regulation by two independent mechanisms. The first involves hydroxylation of proline residues, which leads to proteasomal degradation mediated by the VHL protein. 26, 28, 62, 146 The second involves hydroxylation of an asparagine, which inhibits interaction between HIF-1 and the nuclear coactivator CBP/p300. 20, 57, 89 Under conditions of hypoxia (1-2% O 2 ), these regulatory mechanisms are inhibited and HIF-1 activates HREs, which induce transcription of a number of genes that help the cell "cope" with low O 2 conditions (Fig. 4) . 18 In higher-grade brain tumors, HRMs seem to be overexpressed (unpublished data). 138, 152, 163 Our data from the study of 175 gliomas suggest that high-grade gliomas are more likely to be immunohistochemically positive for HIF-1␣, VEGF, glucose transporter-1, and carbonic anhydrase IX than are low-grade tumors (p = 0.0001 by chisquare testing; (RL Jensen, et al., in press). The expression of HIF-1␣ does not seem to be confined to perinecrotic areas (Fig. 5 ). Increased expression of HRMs in highgrade tumors was confirmed by Western blot analysis performed at the time of surgery on protein extracts from human brain tumors (Fig. 6 ). Benign tumors such as meningiomas, vestibular schwannomas, and endolymphatic sac tumors were included with the various grades of glioma tumors for comparison. A correlation has been suggested between brain tumor grade, vascularity, and HIF-1␣ expression, based on a small series of brain tumors. 163 Glioma cell lines in culture express HRMs in response to hypoxic conditions (RL Jensen, et al., in press). 40, 74, 81, 166 Our data suggest that HIF-1␣ is expressed even under normoxic conditions and that the hypoxic response is exaggerated in a number of GBM cell lines (RL Jensen, et al., in press), especially compared with more benign intracranial tumors (Fig. 7) .
One unanswered question is whether HRM overexpression is simply a result of hypoxic stimulation. Colocalization of HIF-1␣ expression and pimonidazole staining of U87 glioma cell lines have been demonstrated in vitro but not in tumor xenograft experiments. 154, 155 The expression of carbonic anhydrase IX and glucose transporter-1 is inversely distributed relative to vascular perfusion and correlates with polarographic O 2 microelectrodes and pimonidazole staining 4,86,99,108,160 and with HIF-1␣ expression, but there is debate over which "hypoxia marker" is the best. 4, 21 There are also concerns that HRM expression represents a real-time marker of hypoxia (that is, quick changes of cellular levels of HIF-1␣ depending on the cellular O 2 ), whereas biochemical markers of hypoxia bind to hypoxic tissues as a function of drug availability and tissue oxygenation and more likely represent cumulative or "historic" cellular hypoxia.
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Hypoxia Response Element-Controlled Cancer Treatments
A fundamental problem for cancer therapy is the lack of a tumor-selective delivery system. One approach to overcome this, at least in part, is to develop tumor-specific gene expression systems. 136 An HRE is a short segment of nucleotides within a gene's promoter region that is recognized by transcription factors of the HIF family. The HREs from mouse phosphoglycerate kinase and human VEGF or erythropoietin genes have been used to control the expression of marker and therapeutic genes in vitro and in vivo. 11, 123, 124, 135 Multimerized HREs coupled to minimal viral promoters have increased the efficiency of these systems.
15, 136 This approach has been used to increase apoptosis, produce an enzyme necessary for prodrug activation, and rescue postischemic neurons. 15, 23, 124, 136, 137 Post and Van Meir 106 have developed novel HIF-activated systems for cancer therapy, including a bidirectional hypoxia/HIF-responsive expression vector to target gene expression to hypoxic cells. They showed that these vectors have moderate to high inducibility at 1% O 2 but maintain tight regulation under normoxic conditions. With this system, they have produced a conditionally replicative oncolytic virus that can specifically lyse hypoxic tumor cells. 107 In our laboratory, we have used RNA interference technology to target expression of HIF-1 (RL Jensen, unpublished data). We are working to adapt this technology to be under the control of hypoxic stimulation. The RNA interference is triggered by double-stranded RNA in a cell and results in the rapid destruction of messenger RNA that contains an identical or nearly identical sequence.
37,54 Several reports describe successful gene inhibition in mammalian cells that has been achieved with this technique. 22, 24, 35, 93 The ability to induce RNA interference from stably integrated plasmids or virus-producing shRNAs has been demonstrated in vitro and in vivo. 56, 95, 102, 125 Using this approach, p53 gene silencing was accomplished in breast and lung carcinoma cell lines by using adenovirus-delivered siRNA. 134 We have designed siRNAs for HIF-1␣ by searching the coding sequence of HIF-1␣ for two adenines followed by 19 nucleotides that had a GC content of less than 45% and did not contain more than three thymines or adenines in a row. These sequences were tested for possible homology to other human and mouse genes with the Basic Local Alignment Search Tool (http://www.ncbi.nlm.nih.gov/ BLAST). Four potential siRNA sequences were selected, and siRNA was prepared using a Silencer siRNA Construction Kit (Ambion, Inc., Austin, TX). Two DNA primers that contain the sense and antisense siRNA sequence and a short sequence complementary to the T7 Klenow DNA polymerase promoter were annealed and filled in with separate reactions. The T7 polymerase is used for in vitro transcription of the sense and antisense templates, which are then annealed and treated with RNase to digest the GGG overhangs left by T7 polymerase. The product is a 19-nucleotide double-stranded RNA with a UU overhang on each end. A negative control was designed by randomizing the sequence of one of the siRNAs and checking for nonhomology to any human or mouse gene by using the Basic Local Alignment Search Tool.
These constructs were tested for inhibition of HIF-1 activity and VEGF secretion (data not shown). To study stable HIF-1␣ supression, the pSilencer 2.1 U6-hygro plasmid (Ambion, Inc.) was used to express an shRNA that was controlled via the U6 promoter. Two DNA oligonucleotides containing the sense and antisense siRNA sequences separated by a short loop sequence and having BamHI-and HindIII-compatible overhanging ends were annealed and ligated into the linearized pSilencer plasmid. Two siRNA sequences that were found to best suppress HIF-1␣ transiently were used, along with the negative control. U-251 cells were transfected with Fugene transfection reagent (Roche, Nutley, NJ), and transfectants were selected by hygromycin exposure. Stable transfectants were isolated using dilutional cloning and individual clones were tested for VEGF activity to find cell lines with various levels of HIF-1 inhibition (Fig.  8a) . In a similar fashion, the same shRNA constructs were transfected into U251 glioma cell lines that were stably transfected with a luciferase reporter plasmid under the control of an HRE to test HIF-1 activity inhibition directly (Fig. 8b) . All cell lines demonstrate various degrees of decreased VEGF secretion and HIF-1 expression under normoxic and hypoxic conditions (Student t-test, p Ͻ 0.05). However, clones such as RT21 appear to have more HIF-1 inhibition, making them especially interesting for further testing, including in vivo growth measurements, which will be published shortly. We plan to place this expression vector under the control of an HRE to allow for selective targeting of hypoxic cells with specific molecular targets. The U-251 cells were transfected with anti-HIF-1 siRNAexpressing plasmids. Transfectants were selected by hygromycin exposure. Stable transfectants were isolated with dilutional cloning, and individual clones were tested for VEGF activity to find cell lines with various levels of HIF-1 inhibition. b: In a similar fashion, the same shRNA constructs were transfected into a U251 glioma cell line stably transfected with a luciferase reporter plasmid under the control of an HRE. This allows for the direct testing of HIF-1 activity inhibition. All cell lines demonstrate various degrees of decreased VEGF secretion and HIF-1 expression under normoxic and hypoxic conditions (Student t-test, p Ͻ 0.05). However, clones such as RT21 appear to have more HIF-1 inhibition, making them especially interesting for further testing, including in vivo growth measurements.
Conclusions
We hypothesize that the transformation of LGA to GBM is produced by hypoxia-induced phenotypic changes and subsequent clonal selection of cells that overexpress HRMs, such as HIF-1␣. In this model, intratumoral hypoxia causes genetic changes (oncogene activation or tumor suppressor gene inactivation) and produces a microenvironment that selects for cells of a more aggressive phenotype (Fig. 9) . As reviewed earlier, there is convincing evidence that HRMs such as HIF-1␣, VEGF, carbonic anhydrase IX, or glucose transporter-1, may play a role in the tumorigenesis and angiogenesis of a number of malignancies, but their role is unclear in the case of malignant gliomas. 
